Class of: 1982

Ruti Alon

Ruti Alon (Questrom’82) of Herzliya, Israel, was appointed to the board of directors of Treos Bio Limited, a clinical-stage biotechnology company using data science and proprietary biomarkers to develop precision off-the-shelf and personalized peptide cancer immunotherapies. Ruti brings more than 40 years of experience as a life sciences investor, mentor, and leader for private and public biotechnology companies.

From the Fall 2021 issue.